We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
(-83%)
Cap. Flow
-$6.76B
Cap. Flow
% of AUM
-444.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
First Horizon
FHN
|
+$107M |
| 3 |
SGFY
Signify Health, Inc.
SGFY
|
+$54.9M |
| 4 |
VMW
VMware, Inc
VMW
|
+$34.9M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
Rogers Corp
ROG
|
+$432M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.54% |
| 2 | Healthcare | 36.97% |
| 3 | Financials | 14.43% |
| 4 | Communication Services | 3.06% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
26
Agenus
AGEN
$312M
| – | – |
-39,639
| Closed | -$1.59M |
|
|
AISP
27
Airship AI Holdings
AISP
$66.1M
| – | – |
-380,123
| Closed | -$3.77M |
|
28
AlTi Global
ALTI
$481M
| – | – |
-660,509
| Closed | -$6.55M |
|
29
American Homes 4 Rent
AMH
$12.4B
| – | – |
-143,857
| Closed | -$4.72M |
|
30
Amprius Technologies Warrants
AMPX.WS
$500M
| – | – |
-485,383
| Closed | -$150K |
|
31
American Tower
AMT
$79.8B
| – | – |
-3,427
| Closed | -$736K |
|
32
AnaptysBio
ANAB
$1.62B
| – | – |
-81,668
| Closed | -$2.08M |
|
33
Annexon
ANNX
$918M
| – | – |
-121,757
| Closed | -$752K |
|
34
APA Corp
APA
$12.9B
| – | – |
-39,949
| Closed | -$1.37M |
|
35
Air Products & Chemicals
APD
$66.8B
| – | – |
-10,705
| Closed | -$2.49M |
|
36
Aptiv
APTV
$9.61B
| – | – |
-79,278
| Closed | -$6.2M |
|
37
Antero Resources
AR
$10.7B
| – | – |
-41,868
| Closed | -$1.28M |
|
38
Alexandria Real Estate Equities
ARE
$8.34B
| – | – |
-123,123
| Closed | -$17.3M |
|
39
AtriCure
ATRC
$2.01B
| – | – |
-12,300
| Closed | -$481K |
|
40
Aura Biosciences
AURA
$799M
| – | – |
-12,430
| Closed | -$225K |
|
|
AUTL
41
Autolus Therapeutics
AUTL
$532M
| – | – |
-584,406
| Closed | -$1.25M |
|
42
AvalonBay Communities
AVB
$26.6B
| – | – |
-3,675
| Closed | -$677K |
|
43
Avantor
AVTR
$8.91B
| – | – |
-334,170
| Closed | -$6.55M |
|
44
Axogen
AXGN
$2.38B
| – | – |
-225,477
| Closed | -$2.69M |
|
45
Axalta
AXTA
$8.03B
| – | – |
-92,070
| Closed | -$1.94M |
|
46
Axsome Therapeutics
AXSM
$10.8B
| – | – |
-5,000
| Closed | -$223K |
|
|
AZEK
47
DELISTED
The AZEK Co
AZEK
| – | – |
-511,431
| Closed | -$8.5M |
|
48
AstraZeneca
AZN
$250B
| – | – |
-48,215
| Closed | -$5.29M |
|
49
Baxter International
BAX
$14B
| – | – |
-102,838
| Closed | -$5.54M |
|
50
BioAtla
BCAB
$5.53M
| – | – |
-2,240
| Closed | -$862K |
|
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
- UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
- UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.